Black Friday saleUp to 70% OFF
PCI BIOTECH ASA NK 0,03PCI BIOTECH ASA NK 0,03PCI BIOTECH ASA NK 0,03

PCI BIOTECH ASA NK 0,03

No trades
See on Supercharts
Overview
Financials
News Discussions Seasonals

4QG fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

PCI Biotech Holding ASA engages in the research and development of biopharmaceutical products for cancer treatment. Its photochemical internalization technology therapy enhances the effect of anticancer drugs on the body. The company was founded in 2000 and is headquartered in Oslo, Norway.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

4QG does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company